| FDMT |
4D Molecular Therapeutics, Inc. |
Jun 17, 2025 |
1 |
$0 |
4 |
Jun 20, 2025 |
Director |
| MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC. |
Jun 16, 2025 |
1 |
$193K |
4 |
Jun 18, 2025 |
Director |
| TBPH |
Theravance Biopharma, Inc. |
May 19, 2025 |
2 |
$0 |
4 |
May 21, 2025 |
Director |
| MORF |
Morphic Holding, Inc. |
Aug 16, 2024 |
4 |
$0 |
4 |
Aug 20, 2024 |
Director |
| MORF |
Morphic Holding, Inc. |
Jun 4, 2024 |
1 |
$0 |
4 |
Jun 5, 2024 |
Director |
| MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC. |
May 23, 2024 |
1 |
$223K |
4 |
May 24, 2024 |
Director |
| FDMT |
4D Molecular Therapeutics, Inc. |
May 21, 2024 |
1 |
$0 |
4 |
May 23, 2024 |
Director |
| TBPH |
Theravance Biopharma, Inc. |
May 8, 2024 |
2 |
$0 |
4 |
May 10, 2024 |
Director |
| MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC. |
Jul 17, 2023 |
1 |
$0 |
4 |
Jul 19, 2023 |
Director |
| MORF |
Morphic Holding, Inc. |
Jun 1, 2023 |
1 |
$0 |
4 |
Jun 2, 2023 |
Director |
| FDMT |
4D Molecular Therapeutics, Inc. |
May 23, 2023 |
1 |
$0 |
4 |
May 25, 2023 |
Director |
| TBPH |
Theravance Biopharma, Inc. |
May 2, 2023 |
2 |
$0 |
4 |
May 4, 2023 |
Director |
| TBPH |
Theravance Biopharma, Inc. |
Feb 26, 2023 |
4 |
$0 |
4 |
Feb 28, 2023 |
Director |
| TBPH |
Theravance Biopharma, Inc. |
Feb 26, 2023 |
0 |
$0 |
3 |
Feb 28, 2023 |
Director |
| MORF |
Morphic Holding, Inc. |
Jun 8, 2022 |
1 |
$0 |
4 |
Jun 10, 2022 |
Director |
| FDMT |
4D Molecular Therapeutics, Inc. |
May 23, 2022 |
1 |
$0 |
4 |
May 25, 2022 |
Director |
| APR |
Apria, Inc. |
Mar 29, 2022 |
1 |
-$190K |
4 |
Mar 29, 2022 |
Director |
| MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC. |
Nov 19, 2021 |
1 |
$0 |
4 |
Nov 23, 2021 |
Director |
| MORF |
Morphic Holding, Inc. |
Jun 16, 2021 |
1 |
$0 |
4/A |
Apr 29, 2022 |
Director |
| APR |
Apria, Inc. |
Jun 10, 2021 |
1 |
$0 |
4 |
Jun 14, 2021 |
Director |
| FDMT |
4D Molecular Therapeutics Inc. |
May 17, 2021 |
1 |
$0 |
4 |
May 19, 2021 |
Director |
| APR |
Apria, Inc. |
May 4, 2021 |
0 |
$0 |
3 |
May 12, 2021 |
Director |
| MORF |
Morphic Holding, Inc. |
Apr 27, 2021 |
1 |
$0 |
4/A |
Apr 29, 2022 |
Director |